🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/11/2018 | 99,31 | 101,15 | 98,07 | 99,80 | +0,41% | 3,10% | 1.347.963 |
| 05/11/2018 | 103,39 | 105,95 | 99,37 | 99,39 | -3,86% | 6,36% | 7.860.952 |
| 02/11/2018 | 106,65 | 109,09 | 102,31 | 103,38 | -3,25% | 6,36% | 911.306 |
| 01/11/2018 | 102,94 | 107,22 | 102,74 | 106,85 | +3,93% | 4,35% | 1.059.904 |
| 31/10/2018 | 105,16 | 107,34 | 102,00 | 102,81 | -4,78% | 5,08% | 1.367.680 |
| 30/10/2018 | 103,67 | 109,10 | 101,62 | 107,98 | +3,79% | 7,21% | 891.108 |
| 29/10/2018 | 107,72 | 108,57 | 102,45 | 104,04 | -0,17% | 5,68% | 927.977 |
| 26/10/2018 | 103,48 | 107,44 | 102,44 | 104,22 | -1,07% | 4,83% | 1.198.723 |
| 25/10/2018 | 104,49 | 109,05 | 103,58 | 105,35 | +1,13% | 5,24% | 1.305.163 |
| 24/10/2018 | 114,18 | 114,48 | 103,56 | 104,17 | -8,63% | 9,56% | 1.491.912 |
| 23/10/2018 | 112,53 | 114,55 | 109,36 | 114,01 | -1,16% | 4,61% | 1.265.889 |
| 22/10/2018 | 116,79 | 117,84 | 113,28 | 115,34 | -1,40% | 3,90% | 1.412.564 |
| 19/10/2018 | 123,47 | 126,29 | 116,21 | 116,98 | -4,84% | 8,17% | 1.287.209 |
| 18/10/2018 | 126,66 | 130,38 | 122,28 | 122,93 | -2,93% | 6,39% | 979.433 |
| 17/10/2018 | 130,79 | 131,51 | 123,26 | 126,64 | -3,73% | 6,31% | 1.284.003 |
| 16/10/2018 | 125,91 | 133,77 | 125,86 | 131,55 | +5,40% | 6,29% | 1.184.136 |
| 15/10/2018 | 126,38 | 129,75 | 123,27 | 124,81 | -1,24% | 5,13% | 1.149.030 |
| 12/10/2018 | 129,54 | 134,69 | 123,87 | 126,38 | -1,50% | 8,35% | 2.058.893 |
| 11/10/2018 | 132,69 | 137,87 | 128,12 | 128,30 | -3,89% | 7,34% | 2.084.060 |
| 10/10/2018 | 145,80 | 145,86 | 133,36 | 133,50 | -9,01% | 8,57% | 1.742.782 |
| 09/10/2018 | 153,90 | 156,89 | 145,96 | 146,71 | -4,82% | 7,10% | 1.452.478 |
| 08/10/2018 | 158,63 | 160,59 | 152,20 | 154,15 | -2,81% | 5,29% | 704.358 |
| 05/10/2018 | 159,70 | 162,41 | 157,17 | 158,60 | -0,01% | 3,28% | 620.040 |
| 04/10/2018 | 161,63 | 162,43 | 155,45 | 158,62 | -1,90% | 4,32% | 727.762 |
| 03/10/2018 | 167,02 | 167,59 | 156,75 | 161,68 | -3,33% | 6,49% | 1.024.638 |
| 02/10/2018 | 170,31 | 170,93 | 165,91 | 167,26 | -1,48% | 2,95% | 666.207 |
| 01/10/2018 | 172,46 | 173,81 | 169,63 | 169,76 | -0,86% | 2,42% | 592.950 |
| 28/09/2018 | 170,24 | 172,02 | 169,74 | 171,24 | +0,18% | 1,33% | 471.603 |
| 27/09/2018 | 168,43 | 172,25 | 167,19 | 170,94 | +1,82% | 3,00% | 531.234 |
| 26/09/2018 | 169,47 | 170,58 | 167,16 | 167,87 | -0,61% | 2,02% | 546.944 |